Foghorn Therapeutics Inc.
COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
Status:
Application
Type:
Utility
Filling date:
29 Jan 2021
Issue date:
29 Jul 2021